TransMedics to Report Third Quarter 2022 Financial Results on November 3, 2022

Rhea-AI Summary

TransMedics Group, Inc. (TMDX) will release its third-quarter 2022 financial results on November 3, 2022, after market close. A conference call is set for 4:30 p.m. ET to discuss the results, accessible via phone or through a live webcast on their website. TransMedics specializes in organ transplant technology, focusing on improving organ quality and viability for patients with end-stage heart, lung, and liver failure.

ANDOVER, Mass., Oct. 20, 2022 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial results for the third quarter of 2022 after market close on Thursday, November 3, 2022. The TransMedics management team will host a corresponding conference call beginning at 4:30 p.m. ET / 1:30 p.m. PT.

Investors interested in listening to the conference call may do so by dialing (844) 200-6205 for domestic callers or (929) 526-1599 for international callers, followed by Conference ID: 241968. A live and archived webcast of the event will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. 

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
332-895-3222
Investors@transmedics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-report-third-quarter-2022-financial-results-on-november-3-2022-301652196.html

SOURCE TransMedics Group, Inc.

FAQ

When will TransMedics release its third-quarter financial results?

TransMedics will release its third-quarter financial results on November 3, 2022, after market close.

What is the time for the TransMedics conference call?

The conference call will begin at 4:30 p.m. ET on November 3, 2022.

How can I listen to the TransMedics conference call?

Investors can listen to the conference call by dialing (844) 200-6205 for domestic callers or (929) 526-1599 for international callers, using Conference ID: 241968. A live and archived webcast will also be available on their website.

What does TransMedics specialize in?

TransMedics specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation.